SecBot SecBot
6-K ·Filed Oct 13, 2026

RDHL

RedHill Biopharma Ltd.
BEARISH
Impact 6/10
Horizonweeks Processed12d 16h ago SEC0001178913-26-004765
Notable filing: 6-K
Actionable Insight ▼ Bearish

Watch for actual ADS sales under the ATM — each sale will further dilute existing holders and pressure the stock price. The company's cash burn rate and any operational catalysts (e.g., Talicia joint venture progress) will determine whether this capital raise is sufficient to extend runway or merely a stopgap before a more severe restructuring.

DirectionBearish
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
RDHL ▼ -6.42% at T+5d
SHORT call ✓ call won +6.42% · α vs SPY +6.87% · entry $0.4862 → $0.4550
Next anchor: T+20d in 15d
Latest observation: T+7 +12.75% FF3 residual α
Entry anchored
Oct 13, 03:59 PM ET
via 1-min bar
T+1d
+2.65%
call -2.65% · α -2.37%
$0.4991
settled 12d ago
T+5d
-6.42%
call +6.42% · α +6.87%
$0.4550
settled 6d ago
T+20d
Pending
in 15d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

RedHill Biopharma filed a 6-K and prospectus supplement to increase the maximum aggregate offering amount under its existing at-the-market (ATM) offering agreement with H.C. Wainwright to up to $2,587,409 in new ADSs, each representing 10,000 ordinary shares. This capital raise follows a prior going-concern warning (20-F, April 2026) showing only $4.1M cash remaining, and the company's ADS closed at $0.539 on October 9, 2026 — deep distress territory. The filing signals ongoing cash burn and reliance on dilutive equity financing to stay afloat.

Key Facts

  • Company filed a prospectus supplement to increase the maximum aggregate offering amount of ADSs under the ATM agreement to up to $2,587,409.
  • Each ADS represents 10,000 ordinary shares, implying massive per-share dilution if fully drawn.
  • Prior 20-F (April 2026) disclosed only $4.1M cash and substantial doubt about going concern.
  • ADS closing price on October 9, 2026 was $0.539 per ADS, down from $0.90 used in the public float calculation.
  • Only $49,690.55 in gross proceeds had been raised under the ATM in the prior 12 months, indicating very limited market appetite.
  • The offering is subject to the one-third public float limit under General Instruction I.B.5 of Form F-3, with public float calculated at $7,911,299.70.

Financial Impact

Up to $2.59M in new gross proceeds from ADS sales, but at a current market price of $0.539/ADS and each ADS representing 10,000 ordinary shares, the dilution to existing holders is extreme — potentially adding billions of ordinary shares to the outstanding count.

dilutioncash runwayshare count

Risk Factors

  • Extreme dilution from ADS sales at current low prices — each ADS represents 10,000 ordinary shares, so even small dollar raises add massive share count.
  • Going-concern risk remains high given prior disclosure of only $4.1M cash and no new revenue catalysts in this filing.
  • Nasdaq delisting risk persists — the ADS price of $0.539 is well below $1.00 minimum bid price requirement.
  • Limited market appetite for the ATM — only $49,690.55 raised in prior 12 months suggests difficulty accessing capital.

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001178913-26-004765
Exhibit: exhibit_5-2.htm0001178913-26-004765
Exhibit: exhibit_5-1.htm0001178913-26-004765
Document: 0001178913-26-004765-index-headers.html0001178913-26-004765
Document: 0001178913-26-004765-index.html0001178913-26-004765
Document: 0001178913-26-004765.txt0001178913-26-004765
27 reports for RDHL
Performance horizon
88% Hit rate @ T+60 7 of 8 directional calls Went positive at some point 9 of 11 best @ T+60▲ +40.60%Jun 22, 2026
Filters
Rows
Reports for RDHL — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
6-K
NEUTRAL ★ 3/10
$0.4550awaiting T+60—$0.4230 (−7.03%)
Oct 19, 2026
7d ago
6-K
NEUTRAL ★ 3/10
$0.5012awaiting T+60—$0.4230 (−15.60%)
Oct 19, 2026
7d ago
Press Release
NEUTRAL ★ 3/10
$0.5012awaiting T+60—$0.4230 (−15.60%)
Oct 13, 2026
12d ago
6-K
BEARISH ★ 6/10
$0.4862awaiting T+60—$0.4230 (+13.00%)
Oct 13, 2026
12d ago
424B5
BEARISH ★ 6/10
$0.4862awaiting T+60—$0.4230 (+13.00%)
Oct 7, 2026
19d ago
6-K
NEUTRAL ★ 4/10
$0.4740awaiting T+60—$0.4230 (−10.76%)
Sep 1, 2026
7w ago
6-K
BULLISH ★ 7/10
$0.8700awaiting T+60—$0.4230 (−51.38%)
Aug 31, 2026
8w ago
6-K
BULLISH ★ 7/10
$0.9000awaiting T+60—$0.4230 (−53.00%)
Aug 7, 2026
11w ago
6-K
NEUTRAL ★ 3/10
$0.6050awaiting T+60—$0.4230 (−30.08%)
Aug 6, 2026
11w ago
6-K
NEUTRAL ★ 5/10
$0.5810awaiting T+60—$0.4230 (−27.19%)
Showing 10 of 27

US Market Status

Market Closed — Opens in 1h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers